Wellington Management Group LLP raised its stake in shares of Cardiovascular Systems Inc. (NASDAQ:CSII) by 27.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,018,859 shares of the medical device company’s stock after buying an additional 652,962 shares during the period. Wellington Management Group LLP owned about 9.23% of Cardiovascular Systems worth $31,306,000 as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. Schwab Charles Investment Management Inc. increased its stake in shares of Cardiovascular Systems by 3.1% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 98,841 shares of the medical device company’s stock valued at $1,495,000 after buying an additional 2,932 shares during the last quarter. Mairs & Power INC increased its stake in shares of Cardiovascular Systems by 18.6% in the fourth quarter. Mairs & Power INC now owns 246,202 shares of the medical device company’s stock valued at $3,723,000 after buying an additional 38,570 shares during the last quarter. Millennium Management LLC increased its stake in shares of Cardiovascular Systems by 530.2% in the fourth quarter. Millennium Management LLC now owns 245,694 shares of the medical device company’s stock valued at $3,715,000 after buying an additional 206,709 shares during the last quarter. First Manhattan Co. increased its stake in shares of Cardiovascular Systems by 57.8% in the first quarter. First Manhattan Co. now owns 1,434,105 shares of the medical device company’s stock valued at $14,871,000 after buying an additional 525,346 shares during the last quarter. Finally, BlackRock Group LTD increased its stake in shares of Cardiovascular Systems by 48.2% in the first quarter. BlackRock Group LTD now owns 11,854 shares of the medical device company’s stock valued at $123,000 after buying an additional 3,854 shares during the last quarter.
Shares of Cardiovascular Systems Inc. (NASDAQ:CSII) traded up 0.495% during trading on Thursday, hitting $19.295. The company had a trading volume of 211,902 shares. Cardiovascular Systems Inc. has a 12-month low of $7.50 and a 12-month high of $30.38. The firm has a 50 day moving average of $18.48 and a 200 day moving average of $13.70. The stock’s market cap is $630.43 million.
Several analysts have weighed in on CSII shares. Needham & Company LLC raised Cardiovascular Systems from an “underperform” rating to a “buy” rating and set a $16.00 target price on the stock in a research note on Friday, April 1st. Leerink Swann reissued a “hold” rating on shares of Cardiovascular Systems in a research note on Friday, April 1st. Finally, Zacks Investment Research raised Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $21.00 price objective on the stock in a research note on Monday, July 4th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $20.57.
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.
